Prot #145515: NU UCSF15U05: A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 (Ribociclib) in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer

Carneiro Filho, Benedito A (PD/PI)
Hussain, Maha (PD/PI)

Medicine, Hematology Oncology Division

Project: Research project

Status	Finished
Effective start/end date	5/25/16 → 12/31/18

Funding

Prostate Cancer Clinical Trials Consortium, LLC (Prot #145515: NU UCSF15U05 // Prot #145515: NU UCSF15U05)
Novartis Pharmaceuticals Corporation (Prot #145515: NU UCSF15U05 // Prot #145515: NU UCSF15U05)